The state’s health department’s plan of controlled distribution of new tuberculosis drugs limits patient-use in hope of combating multi-drug-resistant tuberculosis (MDR-TB). Committees at government-run medical colleges decide which MDR-TB patients receive each new drug.


Source: Times of India Go to